ZYXI News Alert Zynex Inc (ZYXI) 0.1500 12/25/2014 07:16:40

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Zynex Inc (ZYXI) 0.1500 $ZYXI

Zynex Achieves Compound Pharmacy License Approval in 40th State
Marketwired - Thu Nov 20, 7:57AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today that it attained compound pharmacy licensing approval in the state of Iowa, marking its fortieth state approval.

Zynex's (ZYXI) CEO Thomas Sandgaard on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 2:12PM CST


Zynex beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:04AM CST


Zynex Announces Third Quarter 2014 Results
Marketwired - Fri Nov 07, 7:01AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today its unaudited financial results for the three and nine months ended September 30, 2014.

Zynex reports November 7
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:04AM CST


Zynex Schedules Third Quarter 2014 Earnings Release and Webcast
Marketwired - Fri Oct 31, 3:17PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Friday, November 7 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.

Zynex Hires Michael Frabotta as VP of Sales
Marketwired - Thu Oct 16, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Michael Frabotta as Vice President of Sales. Mr. Frabotta is responsible for Zynex Medical's sales organization, promoting electrotherapy and compound pharmacy products throughout the United States.

Zynex Announces Second Quarter 2014 Results
Marketwire - Thu Sep 25, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today its unaudited financial results for the three and six months ended June 30, 2014.

Zynex Reschedules Second Quarter 2014 Earnings Release and Webcast to September 25, 2014
Marketwire - Wed Sep 17, 5:34PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the date for the Company's second quarter investor webcast has been rescheduled to Thursday, September 25th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.

Zynex Schedules Second Quarter 2014 Earnings Release and Webcast
Marketwire - Wed Sep 10, 2:31PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's second quarter investor webcast on Thursday, September 18th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.

Zynex Announces Brian Alleman as Chief Financial Officer
Marketwire - Mon Jul 21, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the appointment of Brian Alleman as its new chief financial officer.

Zynex Achieves Compound Pharmacy License Approval in 36 States
Marketwire - Tue Jul 15, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has attained compound pharmacy licensing approval in seventeen additional states bringing the total to thirty-six approvals.

Zynex Appoints Director of Business Development
Marketwire - Wed Jun 25, 7:02AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics and compound pharmacy, announced the hiring of Steve Siefring as Director of Business Development. Mr. Seifring will be responsible for driving sales activities in the electrotherapy and compound pharmacy business, reporting to Robert Bird, Vice President of Sales in the US.

ZTE, JD.com Sign CNY3.5bn Agreement
SinoCast - Fri Jan 17, 4:48AM CST
ZTE Corporation January 16 signed a CNY 3.5 billion strategic cooperation agreement with JD.com, which showed that the two will jointly launch the Youth mobile phones.
BSX: 13.13 (+0.07), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), UPI: 2.30 (unch), CYBX: 54.63 (+0.48)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 41

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 70

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 134

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading

Top 5 Most Recently Viewed Articles

Calumet Sets 2025 Plans for Investor Engagement Events

Updated Category News Views 381

Calumet Announces Participation in Upcoming Investor Conferences Calumet, Inc. (NASDAQ: CLMT) is gearing up to make an important presence at two significant investor conferences scheduled for January 2025. The event will offer Calumet a platform to connect with investors and discuss the company's innovative strategies. Goldman Sachs Energy Conference The first conference...

Continue Reading
PACS Group Investors Face Class Action for Alleged Fraud

Updated Category News Views 336

PACS Group Investors Face Class Action for Alleged Fraud In recent developments, a significant class action lawsuit has been initiated against PACS Group, Inc., a recognized leader in the skilled nursing facility sector. The lawsuit, spearheaded by a prestigious law firm, is rooted in serious allegations of securities fraud involving the company and several of its senior...

Continue Reading
Discover the Magic: MINISO Unveils Harry Potter Collection

Updated Category News Views 710

Introducing a Magical Collection from MINISO MINISO, a renowned lifestyle brand celebrated for its affordable quality products, has launched an enchanting array of over 800 Harry Potter-inspired items. This exciting collection will be available in MINISO stores globally, captivating fans of the beloved franchise with affordable yet stylish merchandise that embodies the...

Continue Reading
Westwood Launches Enhanced Income Opportunity ETF for Growth

Updated Category News Views 95

Westwood Launches Enhanced Income Opportunity ETF Westwood Holdings Group, recognized as a leading boutique asset manager, is delighted to announce the creation of the Westwood Enhanced Income Opportunity ETF, also referred to as YLDW. This innovative investment option is a fresh addition to the company’s Enhanced Income Series™ ETFs, which has significantly expanded...

Continue Reading
Upcoming Earnings Announcement: Canadian Pacific Kansas City

Updated Category News Views 161

Canadian Pacific Kansas City to Announce Q2 Earnings Canadian Pacific Kansas City (TSX: CP) has announced its plans to release its financial and operational results for the second quarter of 2025 after market closure. This highly anticipated announcement will take place, giving stakeholders insight into the company's performance and strategic direction. Conference Call...

Continue Reading